DiaMedica Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
-7.52-8.81N/A
Price/Sales ratio
N/A3.020.74
Earnings per Share (EPS)
$-0.82$-0.7N/A

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.64-4.77-4.68-6.79-3.92-5.45-12.93-5.70-3.05-4.77-3.13-3.92
Price/Sales ratio
N/AN/AN/AN/A45.06N/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-2.03-5.608.3636.251.327.636.111.761.311.811.341.32
Price/Cash Flow ratio
-0.82-5.04-3.44-7.42-3.95-6.38-17.31-6.32-3.62-4.93-3.72-3.95
Price/Free Cash Flow ratio
-0.82-5.02-3.43-7.38-3.92-6.38-17.22-6.31-3.60-4.93-3.69-3.92
Price/Earnings Growth ratio
0.010.06-0.26-0.12-1.41-0.261.040.340.15-0.31-0.15-1.41
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A100%N/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/A-1352.2%N/AN/AN/AN/AN/AN/A-1352.2%
Pretax Profit Margin
N/AN/AN/AN/A-1130.8%N/AN/AN/AN/AN/AN/A-1130.8%
Net Profit Margin
N/AN/AN/AN/A-1146.8%N/AN/AN/AN/AN/AN/A-1146.8%
Effective Tax Rate
-0.88%-0.87%-1.01%0.21%-1.41%-0.29%-0.22%-0.20%-0.20%-0.22%-0.20%-1.41%
Return on Assets
-1710.92%-648.61%-118.69%-236.40%-31.26%-117.62%-43.75%-29.83%-39.76%-35.78%-39.76%-117.62%
Return On Equity
315.11%117.32%-178.42%-533.16%-33.67%-139.80%-47.25%-30.87%-42.96%-37.95%-37.62%-139.80%
Return on Capital Employed
316.17%155.63%-199.15%-565.58%-39.67%-149.87%-48.71%-30.99%-43.44%-41.39%-21.41%-39.67%
Liquidity Ratios
Current Ratio
0.140.192.951.4813.866.7013.76N/AN/AN/A15.6013.86
Quick Ratio
0.140.192.951.4813.866.6313.7629.7415.6019.2615.4513.86
Cash ratio
0.110.152.761.3412.982.943.653.082.181.632.182.94
Days of Sales Outstanding
N/AN/AN/AN/A569.4N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/A0.10N/AN/AN/A1.52K173.801.71KN/AN/AN/A1.52K
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A55.17K41.27K46.81KN/A3.16K19.10K7.74K10.71K11.26KN/A3.16K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/A2.92N/AN/A0.000.010.000.000.010.000.070.00
Debt Equity Ratio
N/A-0.52N/AN/A0.000.020.000.000.010.000.080.00
Long-term Debt to Capitalization
N/A-0.46N/AN/A0.000.010.000.000.01N/A0.010.00
Total Debt to Capitalization
N/A-1.12N/AN/A0.000.020.000.000.010.000.010.00
Interest Coverage Ratio
N/A-29.78-51.29N/AN/AN/AN/AN/AN/AN/A-197.14N/A
Cash Flow to Debt Ratio
N/A-2.09N/AN/A-316.44-51.13-77.83-235.61-24.54-225.63-24.54-316.44
Company Equity Multiplier
-0.18-0.181.502.251.071.181.071.031.081.061.081.07
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A-11.39N/AN/AN/AN/AN/AN/A-11.39
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.001.001.001.001.001.001.001.001.001.00
Cash Flow Coverage Ratio
N/A-2.09N/AN/A-316.44-51.13-77.83-235.61-24.54-225.63-24.54-316.44
Short Term Coverage Ratio
N/A-5.22N/AN/AN/A-151.7-141.30-250.04-166.82-225.63-166.82-151.7
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A